title: Is erythropoietin the answer?
authors.affiliation: Departments of Pediatrics, University of California, San Francisco, San Francisco, California 94143, USA.
authors.forename: Fernando F
authors.initials: FF
authors.lastname: Gonzalez
authors.forename: Annie
authors.initials: A
authors.lastname: Fang
authors.forename: Donna M
authors.initials: DM
authors.lastname: Ferriero
mesh_terms: D017209:Apoptosis / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004921:Erythropoietin / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D020925:Hypoxia-Ischemia, Brain / Q000188:drug therapy* / Q000473:pathology*; D007231:Infant, Newborn; D008297:Male; D055495:Neurogenesis / Q000187:drug effects; D012737:Sex Factors
chemical_list: D004921:Erythropoietin